Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Eli Lilly and Co (NYSE:LLY)

79.57
Delayed Data
As of Aug 23
 +0.28 / +0.35%
Today’s Change
67.88
Today|||52-Week Range
92.85
-5.57%
Year-to-Date
Eli Lilly, AstraZeneca Alzheimer's Drug Gets FDA Fast Track
Aug 23 / Zacks.com - Paid Partner Content
Jim Cramer -- Will Interest Rates Rise? Check These 3 Stocks
Aug 17 / TheStreet.com - Paid Partner Content
Intermediate Level Trade: Eli Lilly
Aug 22 / TheStreet.com - Paid Partner Content
Cramer: 3 Stocks Say Interest Rates Are Going Higher
Aug 17 / TheStreet.com - Paid Partner Content
Pharmaceuticals: Staying power
Aug 21 / FT.com - Paid Partner Content
Novo Nordisk A/S Focuses on New Drugs
Aug 16 / MotleyFool.com - Paid Partner Content
US doctors waste millions on branded medicines
Aug 21 / FT.com - Paid Partner Content
Epizyme Doses First Patient in Phase II Mesothelioma Study
Aug 15 / Zacks.com - Paid Partner Content
Better Buy: AbbVie Inc. vs. Eli Lilly & Co.
Aug 17 / MotleyFool.com - Paid Partner Content
Drugmakers hooked on $10bn opioid habit
Aug 10 / FT.com - Paid Partner Content